91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

Tigatuzumab (anti-TNFRSF10B)

功能和特点
  • 规格或纯度: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
  • 反应种属: Cynomolgus,Human
  • 亚型: Human IgG1
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab175677-100μg (试用装)
申请此免费试用装(?)
作为尊贵的客户,您每年可免费申请三次您选择的不同货号试用装产品,尽享探索与享受!
100μg 期货 Stock Image
Ab175677-1mg
1mg 期货 Stock Image
Ab175677-5mg
5mg 期货 Stock Image
Ab175677-10mg
10mg 期货 Stock Image

基本信息

产品名称 Tigatuzumab (anti-TNFRSF10B)
规格或纯度 Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
特异性 TNFRSF10B
反应种属 Cynomolgus,Human
偶联标记 Unconjugated

产品属性

克隆 Recombinant
Format Whole IgG
亚型 Human IgG1
轻链亚型 Kappa
SDS-PAGE 26.3 kDa (Light Chain) & 49.8 kDa (Heavy Chain), under reducing conditions; 177.0 kDa, under non-reducing conditions.
纯化方法 Protein A purified
纯度 >95%
物理外观 Liquid
储存缓冲液 Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 Lot by Lot
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS编号和信息 918127-53-4

关联配体

Ligand ID 9334
名称 tigatuzumab
别名 CS-1008
类别 Antibody
学名 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide
生物活性评价 The affinity of the humanized antibody is not provided in , however the affinity of the original mouse anti-DR5 antibody (TRA-8) from which tigatuzumab is derived provides an approximate affinity (provided in the interaction table below).
评价 Tigatuzumab (CS-1008) is an investigational, humanized agonistic monoclonal antibody directed against human death receptor 5 (TNFRSF10B; a TNF family catalytic receptor for TRAIL), which is expressed on the surface of many types of cancer cells. DR5 contains an intracellular death domain and interacts with FADD (Fas-associated protein with death domain) to mediate apoptisis.
Peptide sequences and structural information for this antibody are available from its IMGT/mAb-DB record. Peptide sequences matching the heavy and light chain variable regions of tigatuzumab are claimed in patent WO2001083560 , but this does not provide an affinity value for the antibody vs. DR5. The antibodies described in the patent were tetsed for their ability to induce apoptosis in cells expressing DR5.
单字母多肽序列
三字母多肽序列
翻译后修饰
化学修饰

相关文档

质检报告COA

请输入批号:


产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

品牌简介

{转码主词}